As a leader in the global chemical industry, LyondellBasell strives every day to be the safest, best operated and most valued company in our industry.
The provision of safe and effective healthcare is one of the most important objectives of any society in the world today. As a consequence, LyondellBasell has developed a full range of polyethylene and polypropylene resins under the brand name Purell, to address customer needs in the healthcare industry.
Purell resins offer excellent aesthetic characteristics , outstanding organoleptic properties , inertia to most chemicals and a full range of stiffness and mechanical resistance.
These resins benefit from LyondellBasell’s Purell Service Concept, offering Pre-testing of material, pharmacopoeia compliance certificates, security of supply, consistency of formulation and dedicated manufacturing procedures to meet customer material requirements for Pharmaceutical packaging,
The Service Concept exemplifies the spirit of pharmaceutical GMP – awareness, change control and documentation and addresses the requirements of the Medical Grade Plastics (MGP) guidelines as developed by the VDI .
The company takes great pride in its world-class technology and customer focus. LyondellBasell has stepped up its circularity and climate ambitions and actions to address the global challenges of plastic waste and decarbonization. In 2022, LyondellBasell was named as one of FORTUNE Magazine’s “World’s Most Admired Companies” for the fifth consecutive year. For more information, please visit www.lyondellbasell.com or follow @LyondellBasell on LinkedIn.
Purell grade EA678P PP for medical device components
Purell EA678P is a new polypropylene (PP) heterophasic copolymer, produced with a non-phthalate based catalytic system and without animal derived components. Purell EA678P exhibits an